Department of Vitreo-Retina, Aravind Eye Hospital, Madurai, India.
Int Ophthalmol. 2021 May;41(5):1689-1695. doi: 10.1007/s10792-021-01725-0. Epub 2021 Feb 8.
To compare outcomes and complications of pars plana vitrectomy (PPV) using a three-dimensional heads-up visualisation system (digitally assisted vitreoretinal system, DAVS) versus conventional analog microscope (CAM) in primary rhegmatogenous retinal detachment (RRD).
This prospective interventional institutional study evaluated 60 eyes of 60 subjects with primary RRD undergoing PPV between September 2017 and February 2018. Subjects were randomly put into DAVS and CAM group and pre-operative ocular characteristics and final outcomes recorded at each visit. All subjects were followed up for a duration of 6 months. Main outcome measures recorded were post-operative retinal status, visual acuity (VA), intraocular pressure (IOP) and surgical complications.
Overall final retinal attachment at 6 months was 91.7% (90% in DAVS eyes and 93.3% in CAM eyes; p = 0.999). Final VA improved significantly from baseline in both groups (p < 0.001). Overall, VA improved to > = 20/40 in 18.3% eyes (6 DAVS, 5 CAM). Median duration of silicone oil endotamponade was 3.5 months (3.5 months in DAVS, 3 months in CAM). Redetachment rate in the series was 25% (20% in DAVS, 30% in CAM). Post-operative proliferative vitreoretinopathy grade C and more was present in 15% of eyes (10% in DAVS, 20% in CAM). Average duration of surgery was 37 ± 6.2 min in DAVS group and 39.8 ± 6.6 min in CAM group (p = 0.09). All steps of vitrectomy could be performed with relative ease and comfort with the DAVS platform.
Anatomical and functional outcomes of RRD were favourable with DAVS and comparable to that with conventional microscope surgery.
比较使用三维抬头可视化系统(数字化辅助玻璃体视网膜系统,DAVS)与传统模拟显微镜(CAM)治疗原发性孔源性视网膜脱离(RRD)的结果和并发症。
本前瞻性干预性机构研究评估了 2017 年 9 月至 2018 年 2 月期间接受玻璃体切除术的 60 例 60 只眼原发性 RRD 患者。将患者随机分为 DAVS 组和 CAM 组,并在每次就诊时记录术前眼部特征和最终结果。所有患者均随访 6 个月。主要观察指标包括术后视网膜状态、视力(VA)、眼内压(IOP)和手术并发症。
6 个月时总体最终视网膜附着率为 91.7%(DAVS 眼为 90%,CAM 眼为 93.3%;p=0.999)。两组的最终 VA 均较基线显著提高(p<0.001)。总的来说,18.3%的眼睛(6 只 DAVS 眼,5 只 CAM 眼)VA 提高到≥20/40。硅油内填塞的中位时间为 3.5 个月(DAVS 为 3.5 个月,CAM 为 3 个月)。该系列的再脱离率为 25%(DAVS 为 20%,CAM 为 30%)。术后增生性玻璃体视网膜病变 C 级及更高级别存在于 15%的眼睛(DAVS 为 10%,CAM 为 20%)。DAVS 组的平均手术时间为 37±6.2 分钟,CAM 组为 39.8±6.6 分钟(p=0.09)。使用 DAVS 平台可以相对轻松舒适地完成玻璃体切除术的所有步骤。
DAVS 治疗 RRD 的解剖和功能结果良好,与传统显微镜手术相当。